# MSA Safety Inc: Form 10-Q for the period ended Sep 30, 2014

- Company: [MSA Safety Inc](/companies/msa.md) (CIK 66570)
- Form: 10-Q
- Filed: 2014-10-23
- Accepted by EDGAR: Oct 23, 2014, 17:12 ET
- Period: 2014-09-30
- Accession: 0000066570-14-000047
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/66570/000006657014000047/a10q-q32014.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/66570/000006657014000047/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2014-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2014-07-01 to 2014-09-30 | $275.7m | us-gaap:Revenues |
| Revenue | 9 months, 2014-01-01 to 2014-09-30 | $823.7m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2014-07-01 to 2014-09-30 | $151.4m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months, 2014-01-01 to 2014-09-30 | $447.5m | us-gaap:CostOfGoodsSold |
| Research and development | 3 months, 2014-07-01 to 2014-09-30 | $13.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2014-01-01 to 2014-09-30 | $36.6m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2014-07-01 to 2014-09-30 | $77.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2014-01-01 to 2014-09-30 | $245.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months, 2014-07-01 to 2014-09-30 | $2.5m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2014-01-01 to 2014-09-30 | $7.6m | us-gaap:InterestExpense |
| Income tax | 3 months, 2014-07-01 to 2014-09-30 | $8.7m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2014-01-01 to 2014-09-30 | $26.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2014-07-01 to 2014-09-30 | $19.3m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2014-01-01 to 2014-09-30 | $55.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2014-07-01 to 2014-09-30 | $0.51 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2014-01-01 to 2014-09-30 | $1.47 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2014-07-01 to 2014-09-30 | $0.52 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2014-01-01 to 2014-09-30 | $1.49 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2014-07-01 to 2014-09-30 | 37,784,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2014-01-01 to 2014-09-30 | 37,708,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2014-01-01 to 2014-09-30 | $50.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2014-01-01 to 2014-09-30 | $24.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2014-01-01 to 2014-09-30 | $34.0m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | at 2014-09-30 | $97.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2014-09-30 | $501.3m | us-gaap:AssetsCurrent |
| Total assets | at 2014-09-30 | $1.26bn | us-gaap:Assets |
| Current liabilities | at 2014-09-30 | $194.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2014-09-30 | $670.6m | us-gaap:Liabilities |
| Long-term debt | at 2014-09-30 | $270.7m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2014-09-30 | $6.7m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2014-09-30 | $584.3m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 33,692 characters.

*The following discussion and analysis should be read in conjunction with the historical financial statements and other financial information included elsewhere in this report on Form 10-Q. This discussion may contain forward-looking statements that involve risks and uncertainties. The forward-looking statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry, business, and future financial results. Our actual results could differ materially from the results contemplated by these forward-looking statements due to a number of factors, including those discussed in the sections of our annual report entitled “Forward-Looking Statements” and “Risk Factors.”*

*On February 27, 2014, Mine Safety Appliances Company, a Pennsylvania corporation ("MSA"), approved the reorganization of the Company into a holding company structure (the “Reorganization”) in accordance with Section 1924(b)(4) of the Pennsylvania Business Corporation Law of 1988. As a result of the Reorganization, Mine Safety Appliances Company became a direct, wholly-owned subsidiary of MSA Safety Incorporated, a Pennsylvania corporation and currently a direct wholly-owned subsidiary of MSA (“New MSA”), and New MSA became the publicly traded holding company of MSA and its subsidiaries. The Reorganization was completed on March 7, 2014. New MSA and its subsidiaries continue to conduct the business and operations that MSA and its subsidiaries conducted immediately prior to the Reorganization. The consolidated assets and liabilities of New MSA and its subsidiaries are identical to the consolidated assets and liabilities of MSA and its subsidiaries immediately prior to the Reorganization.*

*MSA's South African personal protective equipment distribution business and MSA's Zambian operations had historically been part of the International reportable segment. The results of these operations are excluded from continuing operations and are presented as discontinued operations in all periods presented. Please refer to Note 18 Assets Held for Sale and Discontinued Operations, for further commentary on these discontinued operations.*

*Sales from MSA's General Monitors companies were historically reported in the country from which product was shipped. Effective January 1, 2014, the General Monitors business has been fully integrated into MSA. As such, sales made by General Monitors companies are now allocated to each country based on the destination of the end-customer and other criteria based on the value added to the order. The 2013 results presented below have been restated to reflect this change in allocation methodology. Please refer to Note 8 Segment Information, for further information.*

### BUSINESS OVERVIEW

We are a global leader in the development, manufacture and supply of products that protect people’s health and safety. Our safety products typically integrate any combination of electronics, mechanical systems and advanced materials to protect users against hazardous or life threatening situations. Our comprehensive lines of safety products are used by workers around the world in the oil and gas, fire service, mining, construction and other industries, as well as the military. We are committed to providing our customers with service unmatched in the safety industry and, in the process, enhancing our ability to provide a growing line of safety solutions for customers in key global markets.

We tailor our product offerings and distribution strategy to satisfy distinct customer preferences that vary across geographic regions. To best serve these customer preferences, we have organized our business into nine geographical operating segments that are aggregated into three reportable geographic segments: North America, Europe and International. Each segment includes a number of operating segments. In 2013, 50%, 26% and 24% of our net sales were made by our North American, European and International segments, respectively.

*North America*. Our largest manufacturing and research and development facilities are located in the United States. We serve our North American markets with sales and distribution functions in the U.S., Canada and Mexico.

*Europe*. Our European segment includes companies in most Western European countries, and a number of Eastern European countries along with locations in the Middle East and Russia. Our largest European companies, based in Germany and France, develop, manufacture and sell a wide variety of products. Operations in other European segment countries focus primarily on sales and distribution in their respective home country markets. While some of these companies may perform limited production, most of their sales are of products that are manufactured in our plants in Germany, France, the U.S. and China, or are purchased from third party vendors.

*International*. Our International segment includes companies in South America, Africa and the Asia Pacific region, some of which are in developing regions of the world. Principal International segment manufacturing operations are located in Australia, Brazil, China and South Africa. These companies manufacture products that are sold primarily in each company’s home country and regional markets. The other companies in the International segment focus primarily on sales and distribution in their respective home country markets. While some of these companies may perform limited production, most of their sales are of products that are manufactured in our plants in China, Germany, France and the U.S., or are purchased from third party vendors.

- 21-

### PRINCIPAL PRODUCTS

The following is a brief description of each of our principal product categories:

*Core products.* MSA's strategy includes a focus on driving profitable core product sales. Core products include breathing apparatus, industrial head protection, fixed gas and flame detection, portable gas detection and fall protection products. These products receive the highest levels of investment and resources in alignment with our commitment to grow core products sales in both emerging and developed markets.

*Adjacent products.* MSA provides a series of adjacent product offerings to its customers that complement its core products. These products reinforce and extend the core, drawing upon our customer relationships, distribution channels, geographical presence and technical experience. These products tend to have their roots within the core product value chain, but receive a smaller allocation of corporate resources than core products. Adjacent product sales comprise approximately one fourth of consolidated sales.

*Peripheral products.* MSA provides a series of peripheral product offerings to its customers. MSA's competitive advantage in serving peripheral product customers tends to be related to our channels of distribution or customer access. These products are primarily sold to the mining industry and represent a small portion of consolidated sales.

A detailed listing of our significant product offerings in the aforementioned product groups above is included in the MSA's Annual Report on Form 10-K for the year ended December 31, 2013.

- 22-

### RESULTS OF OPERATIONS

### Three Months Ended September 30, 2014 Compared to Three Months Ended September 30, 2013

***Net sales.*** Net sales for the three months ended September 30, 2014 were $275.2 million, an increase of $10.3 million, or 4%, compared with $264.9 million for the three months ended September 30, 2013. The unfavorable translation effects of weakened foreign currencies decreased sales, when stated in U.S. dollars, by $1.6 million. Excluding the effects of weakening currencies, sales increased $11.9 million.

*(In thousands)*

| Net Sales | Three Months Ended September 30, 2014 | 2013 | Dollar Increase (Decrease) | Percent Increase (Decrease) |
| --- | ---: | ---: | ---: | ---: |
| North America | $131,844 | $130,919 | $925 | 1% |
| Europe | 75,785 | 66,360 | 9,425 | 14% |
| International | 67,530 | 67,605 | (75) | —% |
| Total | 275,159 | 264,884 | 10,275 | 4% |

Net sales for the North American segment were $131.8 million in the third quarter of 2014, an increase of $0.9 million, or 1%, compared to $130.9 million in the third quarter of 2013. During the quarter, increased business was evidenced by growth in fixed gas and flame detection, ("FGFD") projects, up $3.3 million. Increased shipments of industrial head protection and respirators also drove growth over the prior year quarter, up $2.7 million and $1.4 million, respectively, as well as smaller increases across other core and adjacent products. These increases were offset by a decline in shipments of breathing apparatus, down $7.2 million. The next generation G1 Self Contained Breathing Apparatus, ("SCBA"), an entirely redesigned SCBA platform, has completed and passed all testing necessary for approval and is now in the final stages of the approval process. The Company currently has 14 patents pending for this product.

Net sales for the European segment were $75.8 million for the third quarter of 2014, an increase of $9.4 million, or 14%, compared to $66.4 million for the third quarter of 2013. Local currency sales in Europe increased $9.3 million over prior year sales in the same period, driven by increased FGFD project business in both Western Europe and in the Middle East, up $5.8 million, as well as increased ballistic helmet, self-contained breathing apparatus, and portable instruments shipments, up $3.6 million, $3.4 million, and $1.5 million, respectively. These increases were partially offset by a decline in shipments of fire helmets and gas masks, down $3.1 million and $1.2 million, respectively, as well as small decreases across a broad range of products. Currency translation effects increased European segment sales, when stated in U.S. dollars, by $0.1 million.

Net sales for the International segment were $67.5 million in the third quarter of 2014, a decrease of $0.1 million, compared to $67.6 million for the third quarter of 2013. Local currency sales in the International segment increased $1.9 million for the quarter on increased shipments of portable instruments and FGFD projects, up $2.3 million and $1.7 million, respectively. Non-core products also supported higher sales over the prior year quarter, up $1.5 million. These increases were partially offset by a lower level of self-contained breathing apparatus and industrial head protection sales, down $2.7 million and $1.3 million, respectively. Currency translation effects decreased International segment sales, when stated in U.S. dollars, by $2.0 million, primarily related to a weaker Argentine peso, Chilean peso, and South African rand. Weakening economic conditions in key emerging markets such as Brazil and South Africa have also contributed to the decline in sales revenue.

***Gross profit.*** Gross profit for the third quarter of 2014 was $123.7 million, an increase of $8.3 million, compared to $115.4 million for the third quarter of 2013. The ratio of gross profit to net sales was 45.0% in the third quarter of 2014 compared to 43.6% in the same quarter last year. The higher gross profit ratio during the current quarter was primarily related to an improved sales order mix, pricing, and lower manufacturing costs.

***Selling, general and administrative expenses.*** Selling, general and administrative expenses were $77.3 million during the third quarter of 2014, an increase of $5.9 million, or 8%, compared to $71.4 million in the third quarter of 2013. Selling, general and administrative expenses were 28.1% of net sales in the third quarter of 2014, compared to 27.0% of net sales in the third quarter of 2013. Local currency selling, general and administrative expenses were $6.4 million higher in the current quarter, on strategic initiatives primarily in the European segment, and increased selling and marketing costs. Currency translation effects decreased current quarter selling, general and administrative expenses, when stated in U.S. dollars, by $0.5 million, primarily related to the weakening of currencies in Latin America.

***Research and development expense.*** Research and development expense was $13.4 million during the third quarter of 2014, an increase of $1.1 million, or 9%, compared to $12.3 million during the third quarter of 2013. The increase reflects general cost increases, our ongoing focus on developing innovative new core products, including the Company's next generation self-contained breathing apparatus.

- 23-

***Restructuring and other charges.*** During the three months ended September 30, 2014, we recorded restructuring charges of $3.6 million ($2.5 million after tax). European segment charges of $3.0 million were related to workforce reductions in Germany, Italy, and Spain and continued steps to execute our Europe 2.0 initiative. International segment charges of $0.6 million were related to severance costs for staff reductions associated with ongoing initiatives to right size our operations in Australia and South Africa.

During the third quarter of 2013, we recorded charges of $1.5 million ($1.1 million after tax). European segment charges of $1.1 million primarily related to staff reductions in Germany and the Netherlands. International segment charges of $0.4 million were related to staff reductions in South Africa and Australia.

***Currency exchange.*** Currency exchange losses were $0.3 million in the third quarter of 2014, compared to losses of $1.8 million in the third quarter of 2013. Currency exchange losses in both quarters were mostly unrealized and related primarily to the effect of the strengthening U.S. dollar on unsettled inter-company balances. Refer to Note 15 to the Condensed Consolidated Financial Statements in Part I Item I of this Form 10-Q, for information regarding our currency exchange rate risk management strategy.

***Income taxes.*** The effective tax rate for the third quarter of 2014 was 32.1% compared to 29.5% for the same quarter last year. The increased effective tax rate in 2014 is primarily due to the lapse of the U.S. research and development (R&D) tax credit at the end of 2013 and a less favorable profile of earnings in the current quarter. The R&D tax credit has not been extended for 2014 as of the end of the third quarter; therefore no R&D tax benefits have been recognized.

***Net income attributable to MSA Safety Incorporated.*** Net income from continuing operations was $18.7 million for the third quarter of 2014, or $0.50 per basic share, a decrease of $0.3 million, or 2%, compared to $19.0 million, or $0.51 per basic share, for the same quarter last year.

North American segment net income for the third quarter of 2014 was $18.0 million, an increase of $1.0 million, or 6%, compared to $17.0 million in the third quarter of 2013. Increased sales and strong gross profit margin, partially offset by a higher effective tax rate, drove performance growth over the third quarter of 2013.

European segment net income for the third quarter of 2014 was $2.6 million, a decrease of $0.5 million, or 16%, compared to net income of $3.1 million during the third quarter of 2013. Local currency net income decreased $0.5 million, reflecting higher selling, general, and administrative expense related to strategic initiatives and higher restructuring costs, partially offset by increased sales and strong profit margins. Currency translation effects, when stated in U.S. dollars, were inconsequential to European segment net income.

International segment net income for the third quarter of 2014 was $2.8 million, a decrease of $2.2 million, or 44%, compared to $5.0 million in the prior year quarter. Local currency net income in the International segment decreased $2.0 million in the current quarter, reflecting flat sales and higher operating expenses. Currency translation effects decreased current quarter International segment net income, when stated in U.S. dollars, by $0.2 million, reflecting a weakening in the Argentine peso and Chilean peso.

The net loss reported in reconciling items for the third quarter of 2014 was $4.8 million compared to a net loss of $6.2 million in the third quarter of 2013. The lower loss during the three months ended September 30, 2014 reflects a favorable currency exchange impact and lower interest expense.

### Nine Months Ended September 30, 2014 Compared to Nine Months Ended September 30, 2013

***Net sales.*** Net sales for the nine months ended September 30, 2014 were $822.7 million, an increase of $2.1 million, compared to $820.6 million for the nine months ended September 30, 2013. The unfavorable translation effects of weaker foreign currencies decreased sales, when stated in U.S. dollars, by $8.2 million. Excluding the effects of weakening currencies, sales increased $10.3 million.

*(In thousands)*

| Net Sales | Nine Months Ended September 30, 2014 | 2013 | Dollar Increase (Decrease) | Percent Increase (Decrease) |
| --- | ---: | ---: | ---: | ---: |
| North America | $400,147 | $402,539 | $(2,392) | (1)% |
| Europe | 229,606 | 207,480 | 22,126 | 11% |
| International | 192,944 | 210,610 | (17,666) | (8)% |
| Total | 822,697 | 820,629 | 2,068 | —% |

- 24-

Net sales by the North American segment were $400.1 million for the nine months ended September 30, 2014, a decrease of $2.4 million, or 1%, compared to $402.5 million for the same period in 2013. Continued industrial market growth was evidenced by increased shipments of portable instruments and head protection, both up $6.6 million, respectively, as well as strength in FGFD projects, up $1.9 million over the same period in 2013. These increases were offset by a decline in shipments of breathing apparatus, associated with approval delays for the G1 SCBA, down $17.5 million.

Net sales for the European segment were $229.6 million for the nine months ended September 30, 2014, an increase of $22.1 million, or 11%, compared to $207.5 million for the same period in 2013. Local currency sales in the European segment increased $16.8 million, driven by increased FGFD project business, up $9.5 million, large ballistic helmet shipments in Western Europe, up $9.3 million, and a $2.1 million increase across other core product lines. These increases were partially offset by decreased shipments of fire helmets and gas masks, down $2.2 million and $2.0 million, respectively. The favorable translation effects of a stronger euro earlier in the year increased European segment sales, when stated in U.S. dollars, by $5.3 million.

Net sales for the International segment were $192.9 million for the nine months ended September 30, 2014, a decrease of $17.7 million, or 8%, compared to $210.6 million for the same period in 2013. Currency translation effects decreased International segment sales, when stated in U.S. dollars, by $13.2 million, related to a weaker Brazilian real, Argentine peso, Chilean peso, Australian dollar, and South African rand. Local currency sales in the International segment decreased $4.5 million for the period. Breathing apparatus, FGFD, and head protection revenue were down $5.0 million, $3.7 million, and $1.6 million, respectively. This decrease was offset by increased portable gas detection and fall protection shipments of $3.8 million and $1.2 million, respectively, as well as smaller increases across a series of non-core products. Weakening economic conditions in key emerging markets such as Brazil and South Africa have also contributed to the decline in sales revenue.

***Gross profit.*** Gross profit for the nine months ended September 30, 2014 was $375.2 million, an increase of $8.4 million, or 3%, compared to gross profit of $366.8 million for the same period in 2013. The ratio of gross profit to net sales was 45.6% in the nine months ended September 30, 2014 compared to 44.7% in the same period last year. The higher gross profit ratio during the current period relates to an improved sales mix and cost management.

***Selling, general and administrative expenses.*** Selling, general and administrative expenses were $245.4 million for the nine months ended September 30, 2014, an increase of $13.3 million, or 6%, compared to $232.1 million for the same period in 2013. Selling, general and administrative expenses were 29.8% of net sales for the nine months ended September 30, 2014, compared to 28.3% of net sales in the same period in 2013. Local currency selling, general and administrative expenses were $15.5 million higher than the same period in 2013, reflecting higher spending on strategic initiatives, including Europe 2.0, increased selling and marketing costs on higher core sales volume, and the Company's focus on improving the customer experience. A decline in post-retirement expense related to the Company's overfunded domestic pension plan and a favorable effect from weakening foreign currencies for the nine months ended September 30, 2014 partially offset these increases. Currency translation effects decreased current quarter selling, general and administrative expenses, when stated in U.S. dollars, by $2.2 million, related to the weakening across several currencies in the international segment, partially offset by the strengthening of the euro earlier in 2014.

***Research and development expense.*** Research and development expense was $36.6 million for the nine months ended September 30, 2014, an increase of $2.3 million, or 7%, compared to $34.3 million for the same period in 2013. The increase reflects general cost increases and our ongoing focus on developing innovative new core products.

***Restructuring and other charges.*** During the nine months ended September 30, 2014, we recorded restructuring charges of $6.4 million ($4.3 million after tax). European segment charges of $4.5 million related primarily to severance from staff reductions in Germany, Italy, and Spain and reorganization costs in Germany. International segment charges of $1.9 million were related to severance from staff reductions in South Africa, Australia and Brazil.

During the nine months ended September 30, 2013, we recorded charges of $3.9 million ($2.8 million after tax), respectively. European segment charges for the nine months ended September 30, 2013 of $2.2 million primarily related to staff reductions in Germany and the Netherlands. International segment charges for the nine months ended September 30, 2013 of $1.7 million were related to staff reductions in Australia.

***Currency exchange.*** Currency exchange losses were $0.4 million for the nine months ended September 30, 2014, compared to losses of $4.1 million for the same period of 2013. Currency exchange losses in both 2014 and 2013 were mostly unrealized and related primarily to the effect of the strengthening of the U.S. dollar on unsettled inter-company balances. Refer to Note 15 to the Condensed Consolidated Financial Statements in Part I Item I of this Form 10-Q, for information regarding our currency exchange rate risk management strategy.

- 25-

***Income taxes.*** The effective tax rate for the nine months ended September 30, 2014 was 32.6% compared to 29.0% for the same period last year. The increased effective tax rate in 2014 is primarily due to the lapse of the U.S. research and development (R&D) tax credit at the end of 2013 and a less favorable profile of earnings in the current year. During the nine months ended September 30, 2013, the Company recognized R&D benefits associated with the full year 2012 as well as a partial amount associated with 2013. The R&D tax credit has not been extended for 2014 as of the end of the third quarter; therefore no R&D tax benefits have been recognized.

***Net income attributable to MSA Safety Incorporated.*** Net income from continuing operations was $54.3 million for the nine months ended September 30, 2014, or $1.45 per basic share, a decrease of $6.6 million, or 11%, compared to $60.9 million, or $1.64 per basic share, for the same period last year.

North American segment net income for the nine months ended September 30, 2014 was $49.7 million, an increase of $3.1 million, or 7%, compared to $46.6 million for the same period in 2013 on improved profitability associated with core products and lower operating expense.

European segment net income for the nine months ended September 30, 2014 was $13.0 million, an increase of $1.3 million, or 11%, compared to net income of $11.7 million for the same period in 2013. Higher sales revenue and strong gross profit was partially offset by higher selling, general, and administrative expenses related to strategic initiatives and higher restructuring costs. Currency translation effects increased European segment net income, when stated in U.S. dollars, by $1.3 million.

International segment net income for the nine months ended September 30, 2014 was $9.0 million, a decrease of $11.6 million, or 56%, compared to $20.6 million for the same period in 2013. Local currency net income in the International segment decreased $9.7 million for the nine months ended September 30, 2014, reflecting a lower level of sales as well as higher selling, general, and administrative expense. Currency translation effects decreased International segment net income, when stated in U.S. dollars, by $1.9 million, primarily reflecting a weaker Brazilian real, Argentine peso, and Chilean peso.

The net loss reported in reconciling items for the nine months ended September 30, 2014 was $17.4 million compared to a net loss of $18.0 million in the same period of 2013. The lower loss during the nine months ended September 30, 2014 reflects higher selling, general, and administrative expense related to corporate strategic initiatives, partially offset by lower interest expense and favorable currency exchange gains.

### LIQUIDITY AND CAPITAL RESOURCES

Our main source of liquidity is operating cash flows, supplemented by borrowings. Our principal liquidity requirements are for working capital, capital expenditures, principal and interest payments on debt, acquisitions and dividend payments. Approximately half of our long-term debt is at fixed interest rates with repayment schedules through 2021. The remainder of our long-term debt is at variable rates, primarily on our unsecured revolving credit facility that is due in 2019. Substantially all of our borrowings originate in the U.S., which has limited our exposure to non-U.S. credit markets and to currency exchange rate fluctuations.

At September 30, 2014, we had cash and cash equivalents totaling $97.4 million, of which $87.9 million was held by our foreign subsidiaries. Cash and cash equivalents are held by our foreign subsidiaries whose earnings are considered indefinitely reinvested at September 30, 2014. These funds could be subject to additional income taxes if repatriated. It is not practicable to determine the potential income tax liability that we would incur if these funds were repatriated to the U.S. because the time and manner of repatriation is uncertain. We believe that domestic cash and cash equivalents, domestic cash flows from operations, annual repatriation of a portion of the current period’s foreign earnings, and availability of our domestic line of credit continue to be sufficient to fund our domestic liquidity requirements.

Cash and cash equivalents increased $1.1 million during the nine months ended September 30, 2014, compared to increasing $13.3 million during the same period in 2013.

- 26-

***Operating activities.*** Operating activities provided cash of $50.8 million during the nine months ended September 30, 2014, compared to providing $64.7 million during the same period in 2013. Lower operating cash flow in 2014 is primarily related to lower net income and unfavorable changes in working capital. Insurance receivables related to cumulative trauma product liability losses were $147.7 million at September 30, 2014 compared to $124.8 million at December 31, 2013. The increase relates to insured cumulative trauma product liability losses and related defense costs. Trade receivables were $200.6 million at September 30, 2014, compared to $200.4 million at December 31, 2013, reflecting a local currency increase of $7.3 million. Inventories were $145.2 million at September 30, 2014, compared to $136.8 million at December 31, 2013, reflecting a local currency inventory increase of $16.2 million. Accounts payable were $67.3 million at September 30, 2014, compared to $66.9 million at December 31, 2013. Local currency accounts payable increased $2.4 million, reflecting our ongoing initiative to improve working capital cash flow.

***Investing activities.*** Investing activities used cash of $24.2 million during the nine months ended September 30, 2014, compared to using $24.9 million in the same period last year, primarily for capital expenditures.

***Financing activities.*** Financing activities used cash of $20.9 million during the nine months ended September 30, 2014, compared to using $23.6 million during the same period in 2013. The change was primarily related to lower stock repurchases, partially offset by fewer stock exercises. During the nine months ended September 30, 2014, we had net borrowings of $9.2 million, primarily from our long-term line of credit. This compared to net borrowings of $10.3 million in the same period in 2013. We paid cash dividends of $34.0 million in the first nine months of 2014 compared to $33.3 million in the same period last year.

The Company's existing debt agreements, including its senior revolving credit facility and note purchase agreements were amended to reflect the changes in the Company's legal structure in March 2014. During this process, we were able to successfully renegotiate a number of our existing credit facilities to provide the Company with access to additional capital, including an additional shelf facility, at historically low interest rates. In June 2014 the Company entered into an additional note facility. Considering these changes and our outstanding debt, the Company currently has access to approximately $598.0 million of capital at September 30, 2014. Refer to Note 12 to the Condensed Consolidated Financial Statements in Part I Item 1 of this Form 10-Q.

### CUMULATIVE TRANSLATION ADJUSTMENTS

The position of the U.S. dollar relative to international currencies at September 30, 2014 resulted in a translation loss of $21.0 million being charged to the cumulative translation adjustments shareholders' equity account during the nine months ended September 30, 2014, compared to a loss of $6.2 million during the same period in 2013. The translation loss during the nine months of 2014 was primarily related to the strengthening of the U.S. dollar against the euro, Argentine peso and Chilean peso. The translation loss during the nine months ended September 30, 2013 was primarily related to the weakening of the South African rand, the Brazilian real, and the Australian dollar, partially offset by the strengthening of the euro.

### COMMITMENTS AND CONTINGENCIES

We made contributions of $3.4 million to our pension plans during the nine months ended September 30, 2014. We expect to make total contributions of approximately $4.5 million to our pension plans in 2014.

The Company had outstanding bank guarantees and standby letters of credit with banks as of September 30, 2014 totaling $6.3 million, of which $2.7 million related to the senior revolving credit facility. These letters of credit serve to cover customer requirements in connection with certain sales orders and insurance companies. No amounts were drawn on these arrangements at September 30, 2014. The Company is also required to provide cash collateral in connection with certain arrangements. At September 30, 2014, the Company has $2.3 million of restricted cash in support of these arrangements. At September 30, 2014, the Company also has a $4.1 million guarantee relating to voluntary retirement payments for its unionized workers in Germany.

We have purchase commitments for materials, supplies, services, and property, plant and equipment as part of our ordinary conduct of business.

Please refer to Note 17 to the Condensed Consolidated Financial Statements in Part I Item 1 of this Form 10-Q for further discussion on the Company's product liabilities.

- 27-

### CRITICAL ACCOUNTING POLICIES AND ESTIMATES

We prepare our consolidated financial statements in accordance with U.S. generally accepted accounting principles (GAAP). The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and the related disclosures. We evaluate these estimates and judgments on an on-going basis based on historical experience and various assumptions that we believe to be reasonable under the circumstances. However, different amounts could be reported if we had used different assumptions and in light of different facts and circumstances. Actual amounts could differ from the estimates and judgments reflected in our financial statements.

The more critical judgments and estimates used in the preparation of our financial statements are discussed in Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2013.

### RECENTLY ADOPTED AND RECENTLY ISSUED ACCOUNTING STANDARDS

Please refer to Note 2 to the Condensed Consolidated Financial Statements in Part I Item 1 of this Form 10-Q.

- 28-

## Market risk

As filed, 2,209 characters.

Market risk represents the risk of adverse changes in the value of a financial instrument caused by changes in currency exchange rates, interest rates, and equity prices. We are exposed to market risks related to currency exchange rates and interest rates.

***Currency exchange rate sensitivity.*** We are subject to the effects of fluctuations in currency exchange rates on various transactions and on the translation of the reported financial position and operating results of our non-U.S. companies from local currencies to U.S. dollars. A hypothetical 10% strengthening or weakening of the U.S. dollar would decrease or increase our reported sales and net income for the nine months ended September 30, 2014 by approximately $41.8 million and $1.8 million, respectively.

When appropriate, we may attempt to limit our transactional exposure to changes in currency exchange rates through contracts or other actions intended to reduce existing exposures by creating offsetting currency exposures. At September 30, 2014, we had open foreign currency forward contracts with a U.S. dollar notional value of $60.9 million. A hypothetical 10% increase in September 30, 2014, forward exchange rates would result in a $6.1 million increase in the fair value of these contracts.

***Interest rates.*** We are exposed to changes in interest rates primarily as a result of borrowing and investing activities used to maintain liquidity and fund business operations. Because of the relatively short maturities of temporary investments, these financial instruments are reported at carrying values that approximate fair values.

At September 30, 2014, we had $146.7 million of fixed rate debt which matures at various dates through 2021. The incremental increase in the fair value of fixed rate long-term debt resulting from a hypothetical 10% decrease in interest rates would be approximately $2.4 million. However, our sensitivity to interest rate declines and the corresponding increase in the fair value of our debt portfolio would unfavorably affect earnings and cash flows only to the extent that we elected to repurchase or retire all or a portion of our fixed rate debt portfolio at prices above carrying values.

## Controls and procedures

As filed, 1,174 characters.

(a) *Evaluation of disclosure controls and procedures.* Based on their evaluation as of the end of the period covered by this Form 10-Q, the Company’s principal executive officer and principal financial officer have concluded that the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)) are effective to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms and (ii) accumulated and communicated to our management, including the principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding disclosure.

(b) *Changes in internal control*. There were no changes in the Company’s internal control over financial reporting that occurred during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

- 29-

Filed Oct 23, 2014.
Source: SEC EDGAR, the filing index for accession 0000066570-14-000047. Last ingested by Listed: Nov 3, 2026, 21:35 ET. No prices; not investment advice.
